What catalytic funding means in global health: a conceptual map of catalytic investment and financing, and what it still leaves unresolved.

US lifetime health spending and health-adjusted life expectancy from 1996 to 2016: was the extra spending worth it?

The hidden economic burden of pancreatitis: lost productivity and socioeconomic impact among working-age adults.

How out-of-pocket healthcare costs impoverish households in Georgia, and what this means for financial protection and universal health coverage.

How co-financing can align health and climate goals: models, examples and challenges for joint investment.

Direct costs of an intensive care unit stay in four European countries, and how a standardised costing methodology makes ICU costs comparable.

WHO’s 2021 guidance on financing common goods for health: what they are and why public financing is needed.

The true cost of type 2 diabetes care: a value measurement study using time-driven activity-based costing.

Health taxes in low- and middle-income countries: how tobacco, alcohol and sugar taxes reduce NCDs and raise revenue.

How out-of-pocket costs affect families of children with type 1 diabetes in Türkiye, and implications for financial protection.

A systematic review of elder financial exploitation: prevalence, risk factors and prevention.

This study by Mitchell et al. (2025) provides the most comprehensive global estimates to date on direct health-care spending related to brain disorders, encompassing…